ChromaCon will be participating in the International Symposium on Continuous Manufacturing of Pharmaceuticals to be held at MIT on May 20-21, 2014.

Janet Woodcock, Head of CDER at the FDA, has asked MIT and the Continuous Manufacturing and Crystallization Consortium (CMAC) to organize a meeting with about 200 participants to align on making continuous pharmaceutical manufacturing a reality. In this symposium, a series of white papers will be presented. The symposium is by invitation only and will bring together pharmaceutical company end users, suppliers, regulators and academics to look at accelerating adoption of continuous manufacturing and how research groups, globally, might collaborate more to help drive this. This is an enormous opportunity to guide the way in which new technologies and new approaches in the pharmaceutical industry can transform quality, cost and service for the benefit of the patient.